Your session is about to expire
← Back to Search
Home-based Virtual Reality Exercise Program for Stroke
N/A
Recruiting
Led By Dahlia Kairy, PhD
Research Sponsored by Université de Montréal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and eight weeks after intervention, as well as 1 and 2 month follow up
Awards & highlights
Study Summary
This trialaims to examine the use of a new telerehabilitation system to improve stroke survivors' arm function and quality of life.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and eight weeks after intervention, as well as 1 and 2 month follow up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and eight weeks after intervention, as well as 1 and 2 month follow up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from Baseline in Upper limb motor control at 8 weeks as measured using the Fugl-Meyer Assessment-UE (FMA-UE)
Secondary outcome measures
Amount of time spent on the actual exe games (moving the arm)
Change from Baseline in Upper limb function at 8 weeks Impact on upper extremity use in daily activities will be using the Motor Activity Log, a self-reported measure of upper limb use
Change from Baseline in Upper limb function at 8 weeks using the Wolf Motor Function Test
+7 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: No Intervention: Usual careExperimental Treatment1 Intervention
All study participants in the control group will receive an 8-week written home exercise program (e.g. GRASP) , i.e. the usual care discharge home program.
Group II: Experimental: Telerehabilitation systemExperimental Treatment1 Intervention
Participants in the experimental group will receive 8 weeks home exercise program using a virtual reality (VR) and telerehabilitation system. The intensity and choice of game for the home program will be determined by the therapist based on the patient's abilities, interests, motivation and fatigue. The patient's performance for the VR home program will be monitored asynchronously and synchronously and the program adapted to ensure it remains at an appropriate level for the patient.
Find a Location
Who is running the clinical trial?
Université de MontréalLead Sponsor
213 Previous Clinical Trials
102,669 Total Patients Enrolled
9 Trials studying Stroke
648 Patients Enrolled for Stroke
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,341 Previous Clinical Trials
26,452,661 Total Patients Enrolled
37 Trials studying Stroke
651,792 Patients Enrolled for Stroke
Dahlia Kairy, PhDPrincipal InvestigatorUniversité de Montréal
1 Previous Clinical Trials
52 Total Patients Enrolled
1 Trials studying Stroke
52 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have shoulder pain that limits your ability to move during the game.You have had a stroke caused by a lack of blood flow or bleeding in the brain, even if it wasn't your first one.You have had a previous arm injury that could make it difficult for you to recover.You have serious problems with thinking or talking.You have trouble seeing.You have a serious problem with balance that makes it unsafe for you to sit without help.You have some difficulty using your arms, but you can still perform basic tasks with them.
Research Study Groups:
This trial has the following groups:- Group 1: No Intervention: Usual care
- Group 2: Experimental: Telerehabilitation system
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the maximum number of participants that this trial can include?
"Affirmative. Per the clinicaltrials.gov website, this trial is actively looking for participants and was initially published on June 27th 2019 with its most recent update occurring November 10th 2022. This medical study aims to enrol a total of 52 patients in one location."
Answered by AI
Is there still capacity for those interested in participating to enroll?
"Affirmative. According to information posted on clinicaltrials.gov, this research is open for enrollment. It was first announced on June 27th 2019 and the details were most recently updated November 10th 2022. To date, 52 participants have been recruited from a single location."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger